Company profile

NurExone Biologic company profile

NurExone Biologic is developing a biological exosome based technology drug platform to treat damage in the Central Nerve System.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2020-01-01

Headquarters

Headquarters
Kinvarra, Connacht, Ireland
Country code
IE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
7
Total equity funding
$5.5M
Last funding
Post Ipo Equity / $457.3K / 2025-09-11
Last equity funding
Post Ipo Equity / $457.3K
Investors
1
Lead investors
1
Founders
1
Articles
80
Exited on
2023-11-10

Founders and investors

Founders

Lior Shaltiel

Lead investors

Israel Innovation Authority

Investors

Israel Innovation Authority

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.